中文 | English
Return
Total: 25 , 1/3
Show Home Prev Next End page: GO
MeSH:(Cladribine*)

1.Hairy cell Leukemia in a Filipino male during the COVID-19 pandemic – report of a rare case

Karmina Vianca A. Viray ; Maribeth Buan Mayo

Philippine Journal of Internal Medicine 2022;60(4):294-297

3.Oral Disease-Modifying Therapies for Multiple Sclerosis.

Woojun KIM ; Manuella Edler ZANDONA ; Su Hyun KIM ; Ho Jin KIM

Journal of Clinical Neurology 2015;11(1):9-19

4.Report of 3 Cases of Hairy Cell Leukemia Treated with 2-Chlorodeoxyadenosine.

Dae Young CHEUNG ; Seok LEE ; Yoo Jin KIM ; Yoon Hee PARK ; Seung Ki KWOK ; Hye Jung LEE ; Hee Je KIM ; Dong Wook KIM ; Jong Wook LEE ; Woo Sung MIN ; Chun Choo KIM

Korean Journal of Hematology 2002;37(4):292-296

5.Recurrent and Refractory Langerhans Cell Histiocytosis in Children Treated with the Combination of Cladribine and Cytarabine.

Yu DU ; Hao XIONG ; Hui LI ; Jian-Xin LI ; Fang TAO ; Li YANG ; Wen-Jie LU ; Shan-Shan QI ; Lan-Nan ZHANG

Journal of Experimental Hematology 2022;30(3):943-949

7.Cladribine for 13 cases refractory high-risk children Langerhans cell histiocytosis.

Tao HU ; Rong LIU ; Junhui LI ; Jing CAO ; Lei ZHANG ; Juanjuan LI ; Wei FAN ; Dixiao ZHONG ; Xiaodong SHI

Chinese Journal of Hematology 2014;35(11):985-989

8.Cladribine treatment of repeatedly-relapsed Langerhans cell histiocytosis: a case report and literature review.

Xie YAO ; Hua YING ; Zhao WEIHONG ; Sun QING ; Lu XINTIAN

Chinese Journal of Pediatrics 2015;53(4):296-299

9.Efficacy and Safety of Cladribine-based Intensified Conditioning Regimen in Hematopoietic Stem Cell Transplantation in Patients with High-Risk Acute Myeloid Leukemia.

Wan-Ying PAN ; Ke-Xin LI ; Hui-Yang WU ; Ying-Zhi HE ; Jing-Wen DU ; Ya-Ling ZHENG ; San-Fang TU ; Chao-Yang SONG ; Yu-Hua LI ; Yu-Xian HUANG

Journal of Experimental Hematology 2022;30(1):65-71

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 25 , 1/3 Show Home Prev Next End page: GO